Candel Therapeutics

Candel Therapeutics is pioneering oncolytic virus-based approaches to elicit a broad, potent immune response against solid tumors and their metastases to save, extend, and improve the lives of cancer patients. By reactivating the immune system, Candel’s clinical-stage product candidates can potentially lead to the achievement of disease remission not available with current immunotherapies.